Bank Of Montreal Halozyme Therapeutics, Inc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 524,931 shares of HALO stock, worth $31.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

524,931

Previous 519,430 1.06%

Holding current value

$31.8 Million

Previous $21.1 Million 30.08%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$37.81 - $52.4 $207,992 - $288,252	5,501 Added 1.06%	524,931 $27.5 Million
Q1 2024 May 13, 2024	BUY	$33.68 - $41.95 $501,427 - $624,551	14,888 Added 2.95%	519,430 $21.1 Million
Q4 2023 Feb 08, 2024	BUY	$33.32 - $42.1 $1.73 Million - $2.19 Million	51,943 Added 11.48%	504,542 $18.6 Million
Q3 2023 Nov 01, 2023	SELL	$36.46 - $44.03 $1.19 Million - $1.44 Million	-32,619 Reduced 6.72%	452,599 $17.3 Million
Q2 2023 Aug 02, 2023	BUY	$30.28 - $38.74 $5.12 Million - $6.56 Million	169,245 Added 53.56%	485,218 $17.5 Million
Q1 2023 Jun 13, 2024	SELL	$32.86 - $55.7 $1.55 Million - $2.62 Million	-47,085 Reduced 9.06%	472,345 $18 Million
Q4 2022 Feb 01, 2023	SELL	$40.06 - $59.44 $4.62 Million - $6.86 Million	-115,423 Reduced 26.76%	315,973 $18 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $15.8 Million - $21.3 Million	411,341 Added 2051.06%	431,396 $17.5 Million
Q2 2022 Aug 11, 2022	BUY	$37.35 - $48.3 $56,398 - $72,933	1,510 Added 8.14%	20,055 $941,000
Q1 2022 May 12, 2022	BUY	$31.97 - $41.06 $15,921 - $20,447	498 Added 2.76%	18,545 $746,000
Q4 2021 Feb 11, 2022	SELL	$31.82 - $40.75 $3.2 Million - $4.1 Million	-100,702 Reduced 84.8%	18,047 $736,000
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $94,020 - $113,450	-2,444 Reduced 2.02%	118,749 $4.71 Million
Q2 2021 Aug 12, 2021	BUY	$38.84 - $51.31 $4.71 Million - $6.22 Million	121,193 New	121,193 $5.55 Million

Others Institutions Holding HALO

# of Institutions

519

Shares Held

124M

Call Options Held

208K

Put Options Held

77.1K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.45B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account